carmustine has been researched along with Leukemia, Pre-B-Cell in 2 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Messinger, Y | 1 |
| Yanishevski, Y | 1 |
| Avramis, VI | 1 |
| Ek, O | 1 |
| Chelstrom, LM | 1 |
| Gunther, R | 1 |
| Myers, DE | 1 |
| Irvin, JD | 1 |
| Evans, W | 1 |
| Uckun, FM | 1 |
| Bassan, R | 1 |
| Rohatiner, AZ | 1 |
| Lerede, T | 1 |
| Di Bona, E | 1 |
| Rambaldi, A | 1 |
| Pogliani, E | 1 |
| Rossi, G | 1 |
| Fabris, P | 1 |
| Morandi, S | 1 |
| Casula, P | 1 |
| Carter, M | 1 |
| Lambertenghi-Deliliers, G | 1 |
| Lister, TA | 1 |
| Barbui, T | 1 |
2 other studies available for carmustine and Leukemia, Pre-B-Cell
| Article | Year |
|---|---|
Treatment of human B-cell precursor leukemia in SCID mice using a combination of the investigational biotherapeutic agent B43-PAP with cytosine arabinoside.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarab | 1996 |
Role of early anthracycline dose-intensity according to expression of Philadelphia chromosome/BCR-ABL rearrangements in B-precursor adult acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols | 2000 |